57 related articles for article (PubMed ID: 11114114)
1. Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence.
Amir-Zaltsman Y; Mazor O; Gayer B; Scherz A; Salomon Y; Kohen F
Luminescence; 2000; 15(6):377-80. PubMed ID: 11114114
[TBL] [Abstract][Full Text] [Related]
2. Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells.
Yang EB; Wang DF; Mack P; Cheng LY
Biochem Biophys Res Commun; 1996 Jul; 224(2):309-17. PubMed ID: 8702388
[TBL] [Abstract][Full Text] [Related]
3. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
4. Spatial organization of EGF receptor transmodulation by PDGF.
Liu P; Anderson RG
Biochem Biophys Res Commun; 1999 Aug; 261(3):695-700. PubMed ID: 10441488
[TBL] [Abstract][Full Text] [Related]
5. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
6. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
9. Secretin regulates paracellular permeability in canine gastric monolayers by a Src kinase-dependent pathway.
Chen MC; Solomon TE; Perez Salazar E; Kui R; Rozengurt E; Soll AH
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G893-9. PubMed ID: 12223349
[TBL] [Abstract][Full Text] [Related]
10. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
11. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor.
Yoshida J; Ishibashi T; Nishio M
Cancer Res; 2001 Aug; 61(16):6151-7. PubMed ID: 11507066
[TBL] [Abstract][Full Text] [Related]
12. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
13. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
14. A FRET-based probe for epidermal growth factor receptor bound non-covalently to a pair of synthetic amphipathic helixes.
Itoh RE; Kurokawa K; Fujioka A; Sharma A; Mayer BJ; Matsuda M
Exp Cell Res; 2005 Jul; 307(1):142-52. PubMed ID: 15922734
[TBL] [Abstract][Full Text] [Related]
15. Development of a time-resolved fluorescent assay for measuring tyrosine-phosphorylated proteins in cells.
Waddleton D; Ramachandran C; Wang Q
Anal Biochem; 2002 Oct; 309(1):150-7. PubMed ID: 12381374
[TBL] [Abstract][Full Text] [Related]
16. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
El-Obeid A; Hesselager G; Westermark B; Nistér M
Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176
[TBL] [Abstract][Full Text] [Related]
17. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
Xuan Y; Hacker MP; Tritton TR; Bhushan A
Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
19. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of monoclonal antibodies to phosphotyrosine and their use for identification of phosphotyrosine-containing proteins].
Kharitonenkov AI; Kudriavtseva NG; Bulargina TV
Biokhimiia; 1989 Oct; 54(10):1732-9. PubMed ID: 2481508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
